AU1102595A - Modified oligonucleotides, method for producing them and use as active substances - Google Patents

Modified oligonucleotides, method for producing them and use as active substances

Info

Publication number
AU1102595A
AU1102595A AU11025/95A AU1102595A AU1102595A AU 1102595 A AU1102595 A AU 1102595A AU 11025/95 A AU11025/95 A AU 11025/95A AU 1102595 A AU1102595 A AU 1102595A AU 1102595 A AU1102595 A AU 1102595A
Authority
AU
Australia
Prior art keywords
producing
active substances
modified oligonucleotides
oligonucleotides
modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU11025/95A
Inventor
Helmut Brunar
Christian Noe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU1102595A publication Critical patent/AU1102595A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
AU11025/95A 1993-12-13 1994-12-13 Modified oligonucleotides, method for producing them and use as active substances Abandoned AU1102595A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT0250593A AT407639B (en) 1993-12-13 1993-12-13 MODIFIED OLIGONUCLEOTIDS, METHOD FOR THE PRODUCTION THEREOF AND USE AS ACTIVE SUBSTANCES FOR THE PRODUCTION OF MEDICINAL PRODUCTS
AT2505/93 1993-12-13
PCT/AT1994/000195 WO1995016696A2 (en) 1993-12-13 1994-12-13 Modified oligonucleotides, method for producing them and use as active substances

Publications (1)

Publication Number Publication Date
AU1102595A true AU1102595A (en) 1995-07-03

Family

ID=3535494

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11025/95A Abandoned AU1102595A (en) 1993-12-13 1994-12-13 Modified oligonucleotides, method for producing them and use as active substances

Country Status (3)

Country Link
AT (1) AT407639B (en)
AU (1) AU1102595A (en)
WO (1) WO1995016696A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4613796A (en) * 1995-02-10 1996-08-27 Jorg Kreuter Medicament in particle form

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5418290A (en) * 1989-03-31 1990-11-05 University Patents Inc. Polynucleotide phosphorodithioates as therapeutic agents for retroviral infections
BR9105935A (en) * 1990-01-11 1992-11-17 Isis Pharmaceuticals Inc COMPOSITION, OLIGONUCLEOTIDEO ANALOG, MIXED SEQUENCED OLIGONUCLEOTIDEO, PROCESS FOR THE PREPARATION OF 2'-SUBSTITUTED NUCLEOSASES PREPARATION, COMPOSITION TO MODULATE THE RNA ACTIVITY, PROCESSES TO MODULAR THE PRODUCTION OF A PROTEIN FOR AN ORGANIC PROTECTION OR ABSENCE OF RNA, OLIGONUCLEOTIDEO OR NUCLEASE RESISTANT OLIGONUCLEOTIDE ANALOG ANALOG AND PROCESS TO TREAT AN ORGANISM HAVING A DISEASE
IL104965A (en) * 1992-03-05 1999-11-30 Isis Pharmaceuticals Inc Covalently cross-linked oligonucleotides
AU4684993A (en) * 1992-07-23 1994-02-14 Isis Pharmaceuticals, Inc. Novel 2'-o-alkyl nucleosides and phosphoramidites processes for the preparation and uses thereof

Also Published As

Publication number Publication date
WO1995016696A3 (en) 1995-07-20
ATA250593A (en) 2000-09-15
AT407639B (en) 2001-05-25
WO1995016696A2 (en) 1995-06-22

Similar Documents

Publication Publication Date Title
AU694647B2 (en) Acetamide derivatives, process for producing the same, and medicinal composition containing the same
EP0710667B8 (en) Modified oligonucleotides, their preparation and their use
AU4826196A (en) Cyclic compounds, their production and use
AU2513195A (en) Superabsorbent foams, and method for producing the same
AU7106096A (en) Catalyst composition and methods for using and preparing same
AU4802896A (en) Phosphonomonoester nucleic acids, process for their preparation, and their use
AU6373094A (en) Enzyme-containing pharmaceutical or cosmetic composition, process for preparing the same and its use
AU7763494A (en) Catalysts, process in which they can be used and process for preparing them
AU6432094A (en) Staple and semi-staple oligonucleotides, method of preparation and applications
HUP9900375A3 (en) Transdermal matrix system, its use and process for producing the same
AU7227394A (en) Method for surface treatment, means for carrying out the method and the use thereof
AU5123996A (en) Bactericidal mat, process for producing the same, and use thereof
AU2465695A (en) Structure forming method, apparatus and the resulting product
AU7817994A (en) Catalytic process
AU692710B2 (en) Intercalation compounds, method for preparing them and use thereof, particularly in pyrotechnics
AU5922694A (en) 2-amino-4-quinolyl-dihydropyridines, processes for their preparation, and their use
AU7552098A (en) Physiologically active substances tkr2449, process for producing the same, and microorganism
AU3694795A (en) Novel oligomers, process for their preparation and methods for their use
AU5320998A (en) Microparticles containing active substances, agents containing the same, their use in ultrasound-controlled releasing of active substances as well as the method for their production
AU697639B2 (en) Hard tissue intactly dissolved materials and method for producing the same
AU1944799A (en) Hyperhydrated citicoline, process and use
AU1102595A (en) Modified oligonucleotides, method for producing them and use as active substances
AU3116495A (en) Catalyst, use thereof and process for preparation thereof
AU7304196A (en) Topical liquid composition, method for preparing same and uses thereof
AU3945493A (en) Paired-ion oligonucleotides and methods for preparing same